Loading
HKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$4.425
−HK$0.01 · -0.23%
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Latest quote
HK$4.425
−HK$0.01 · -0.23%
Regular session · HKT · Market data may be delayed.
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Day range
Current HK$4.425
52-week range
Current HK$4.425
Regular session · HKT · Market data may be delayed.
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Day range
Current HK$4.425
52-week range
Current HK$4.425
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.1349
2025 complete year+12.4% since 2021
2026 partial: HK$0.139
HK$0.12
2,021
HK$0.15
2,022
HK$0.16
2,023
HK$0.2605
2,024
HK$0.1349
2,025
HK$0.139
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 10, 2026 | HK$0.1006Quarterly | Sep 14, 2026 | Oct 30, 2026 |
Dividend | Jun 17, 2026 | HK$0.139Irregular | Jun 18, 2026 | Aug 3, 2026 |
Dividend | Sep 11, 2025 | HK$0.0789Semi-Annual | Sep 12, 2025 | Oct 31, 2025 |
Dividend | May 28, 2025 | HK$0.056Semi-Annual | May 29, 2025 | Jul 14, 2025 |
Dividend | Sep 10, 2024 | HK$0.0908Semi-Annual | Sep 11, 2024 | Oct 30, 2024 |
Dividend | Jun 4, 2024 | HK$0.1697Semi-Annual | Jun 5, 2024 | Jul 19, 2024 |
Ex-dividend Sep 10, 2026
HK$0.1006
Quarterly
Record Sep 14, 2026 · Payment Oct 30, 2026
Ex-dividend Jun 17, 2026
HK$0.139
Irregular
Record Jun 18, 2026 · Payment Aug 3, 2026
Ex-dividend Sep 11, 2025
HK$0.0789
Semi-Annual
Record Sep 12, 2025 · Payment Oct 31, 2025
Ex-dividend May 28, 2025
HK$0.056
Semi-Annual
Record May 29, 2025 · Payment Jul 14, 2025
Ex-dividend Sep 10, 2024
HK$0.0908
Semi-Annual
Record Sep 11, 2024 · Payment Oct 30, 2024
Ex-dividend Jun 4, 2024
HK$0.1697
Semi-Annual
Record Jun 5, 2024 · Payment Jul 19, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS16.41M0.00%646.2B USD0.05%$88.41+0.50%
Vanguard FTSE Emerging Markets ETFVWO16.34M0.01%162.3B USD0.06%$61.44+0.74%
iShares Core MSCI Emerging Markets ETFIEMG11.36M0.01%163.85B USD0.09%$83.65+1.65%
JPMorgan International Value ETFJIVE5.59M0.14%3.99B USD0.55%$100.08+0.26%
Vanguard FTSE All-World ex-US ETFVEU2.58M0.00%95.9B USD0.04%$86.41+0.54%
First Trust Emerging Markets AlphaDEX FundFEM2.48M0.30%817.4M USD0.80%$33.5706+0.52%
Vident International Equity Strategy ETFVIDI1.97M0.43%393.41M USD0.61%$41.64+0.52%
Avantis Emerging Markets Equity ETFAVEM1.78M0.01%28.73B USD0.33%$96.81+1.52%Vanguard Total International Stock ETFVXUSVanguard FTSE Emerging Markets ETFVWOiShares Core MSCI Emerging Markets ETFIEMGJPMorgan International Value ETFJIVEVanguard FTSE All-World ex-US ETFVEUFirst Trust Emerging Markets AlphaDEX FundFEMVident International Equity Strategy ETFVIDIAvantis Emerging Markets Equity ETFAVEMAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
